Related Experiment Video
Updated: May 21, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Approach to cardiovascular disease prevention in patients with chronic kidney disease
1Division of Cardiology and Department of Medicine, Emory University, Atlanta, GA, USA.
Insights
Preventing cardiovascular disease (CVD) in chronic kidney disease (CKD) requires managing multiple risk factors. Early intervention with lifestyle changes and medications is key to reducing CVD events and slowing CKD progression.
Area of Science:
- Nephrology and Cardiovascular Medicine
- Public Health and Preventive Medicine
Background:
- Chronic kidney disease (CKD) significantly increases cardiovascular disease (CVD) risk, leading to higher event rates and mortality.
- A complex, bidirectional relationship exists between CKD and CVD, necessitating integrated management strategies.
- Early identification of high-risk individuals is crucial for effective CVD prevention in the CKD population.
Purpose of the Study:
- To outline a multidisciplinary approach for preventing CVD in patients with CKD.
- To identify rational targets and effective intervention strategies for managing cardiovascular risk factors in CKD.
Main Methods:
- Review of evidence on the relationship between CKD and CVD.
- Identification of key risk factors and potential intervention targets.
- Discussion of lifestyle modifications and pharmacological therapies.
Main Results:
- Optimal blood pressure control, proteinuria reduction, dyslipidemia treatment, diabetes management, smoking cessation, salt restriction, healthy BMI, anemia correction, and mineral metabolism management are rational targets.
- Lifestyle modifications and medications like renin-angiotensin blockers, beta-blockers, diuretics, statins, and aspirin are recommended.
- Evidence for the benefit of some interventions in CKD patients requires further demonstration.
Conclusions:
- Preventing CVD in CKD is complex, demanding a multidisciplinary team and well-defined programs.
- A combination of lifestyle changes and pharmacological interventions, initiated early in CKD, is essential.
- Targeted risk factor management is critical for improving outcomes in patients with CKD and CVD.
Opinion Statement:
Chronic kidney disease (CKD) is associated with a large burden of cardiovascular risk factors ultimately leading to increased cardiovascular events and mortality. Prevention of cardiovascular disease (CVD) in CKD involves early identification of individuals at high-risk of renal disease. In fact, substantial evidence points to a complex bidirectional relationship between CKD and CVD. Therefore, most interventions directed at CKD prevention should include multiple risk factor interventions with the goal of preventing CVD events while slowing progression of CKD. Clearly, prevention of CVD in CKD is a complex task and requires a multidisciplinary team approach, with a well-defined program, rational targets for each risk factor, and implementation of the most effective intervention strategies. Although several interventions to prevent CVD have proven effective in the general population and in individuals at high risk for CVD, a true benefit in patients with CKD remains to be demonstrated for several of them. A few rational targets of intervention should be optimal blood pressure control, reduction of proteinuria, treatment of dyslipidemia, good control of diabetes, smoking cessation, dietary salt restriction, achievement of normal body mass index, partial correction of anemia, and management of mineral metabolism abnormalities. Lifestyle modification and pharmacological therapy with renin-angiotensin blockers, β-blockers, diuretics, statins, and aspirin should be encouraged in the early stages of CKD.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Coronary Artery Disease IV: Preventive Measures
